There are a number of interventions that can help people living with dementia improve their memory and thinking skills and to enable them to cope better, or even slightly delay the loss of memory. In this podcast we discuss Cognitive Stimulation Therapy (CST) – an intervention which has been significantly researched and supported by a large amount of evidence.

In this ISTAART Research Perspectives Special, Global Brain Health Institute (GBHI) Fellows Fernando Peres and Dr Clara Domínguez Vivero talk with CST expert and researcher Dr Elisa França Resende and Alzheimer’s Association Volunteer and person living with dementia Pam Montana. Our two guests give two perspectives from each side of the treatment, researcher and provider and recipient and user. Exploring the research and how CST has helped to support Pam to live with the progressive symptoms of dementia.

-- Fernando Perez is a Journalist, Writer and GHBI Fellow based in Brazil.

-- Dr Clara Dominguez Vivero is a Neurologist, PhD holder, Neuroinflammation Researcher and GHBI Fellow based at Hospital Clínico Universitario de Santiago de Compostela.

-- Dr Elisa de Paula França Resende is a Neurologist and GBHI Fellow, researching Cognitive Reserve and dementia in people with low education at Federal University of Minas Gerais (UFMG), Brazil.

-- Pam Montana was diagnosed with young-onset Alzheimer’s disease in 2016 at the age of 61. A former Intel executive, Pam managed and led sales teams until her early retirement in 2017. Pam is a champion for dementia research and a former member of the Alzheimer’s Association National Early-Stage Advisory Group.

Find out more about our hosts and guests and review a full transcript of this podcast on our website at

https://www.dementiaresearcher.nihr.ac.uk/podcast

Further Reading:

CST to Maintain Memory - https://bit.ly/3quKXC5

CST Toolkit - https://bit.ly/33xjBSD

GBHI - https://www.gbhi.org/

For information on ISTAART Visit – https://www.alz.org/istaart

--

This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK and Alzheimer's Society, who we thank for their ongoing support.